Choroid Plexus Carcinoma
Associated Genetic Biomarkers
NCI Definition: A malignant neoplasm arising from the choroid plexus. It shows anaplastic features and usually invades neighboring brain structures. Cerebrospinal fluid metastases are frequent. (Adapted from WHO) 
There are 2 clinical trials for choroid plexus carcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain choroid plexus carcinoma as an inclusion criterion, 1 is phase 1 (1 open) and 1 is phase 2 (1 open).
Nivolumab and patient-derived wt1/prame/survivin-specific cytotoxic t-lymphocytes are the most common interventions in choroid plexus carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.